Search results

  • ...apy for the management of diabetes: past, present, and future of intensive therapy]. Diabetes spectrum: a publication of the American Diabetes Association. 20 [[File:Insulin pump with infusion set.jpg|thumb|Insulin pump with infusion set]]
    6 KB (841 words) - 11:25, 5 April 2023
  • ...ormone]] made by beta cells in the [[Pancreatitis|pancreas]]. When we eat, insulin is released into the [[Blood Physiology|blood]] stream where it helps to mo ...produce insulin have been destroyed by an autoimmune reaction in the body. Insulin replacement by daily injections is required.
    8 KB (1,107 words) - 15:23, 30 August 2023
  • [[File:Insulinresistance.jpeg|thumb|360x360px|Insulin Resistance]] ...ion. Insulin resistance (IR) refers is to an impaired biologic response to insulin stimulation of target tissues, essentially the liver, [[Muscle Cells (Myocy
    6 KB (815 words) - 06:56, 21 August 2022
  • ...as increase the release of [[Insulin in the Treatment of Diabetes Mellitus|insulin]] through the stimulation of pancreatic beta cells. Sulfonylureas, conseque ...<ref>Ahrẻn B. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag. 2013; 9: 155-163</ref> Patients
    4 KB (582 words) - 06:52, 8 February 2023
  • ...e 1 diabetes]], particularly in those patients receiving intensive insulin therapy. Patients with [[Diabetes Mellitus Type 2|type II diabetes]] experience hyp [[File:Glucose insulin day.png|right|frameless|399x399px]]
    8 KB (1,023 words) - 18:22, 24 January 2023
  • ...ycemia and subsequent ketoacidosis are infection, non-adherence to insulin therapy, acute major illnesses like [[Myocardial Infarction|myocardial infarction]] ...e of which is the ketogenesis pathway is determined by the availability of insulin in proportion to the counter-regulatory [[Hormones|hormone]]<nowiki/>s.
    10 KB (1,371 words) - 06:24, 24 September 2021
  • ...>Medline plus IGF 1 Test Available:https://medlineplus.gov/lab-tests/igf-1-insulin-like-growth-factor-1-test/ (accessed 16.8.2022)</ref> ...fects: HGH impacts metabolism primarily by up-regulating the production of insulin-like growth factor-1 and its subsequent effect on peripheral cells. Predomi
    7 KB (1,015 words) - 13:45, 20 August 2022
  • ...Autoimmune Disorders|autoimmune disease]] that leads to the destruction of insulin-producing pancreatic beta cells. ...e, lipid, protein, and mineral metabolism, as well as growth; importantly, insulin allows glucose to enter [[Muscle Cells (Myocyte)|muscle]] and adipose cells
    14 KB (1,996 words) - 18:03, 22 March 2022
  • ..., low food intake, any systemic inflammation, poor response to anti cancer therapy. ...advanced cancer OR rapidly progressive cancer, unresponsive to anticancer therapy. Associated with active catabolism and the factors associated with active m
    10 KB (1,429 words) - 14:20, 14 December 2022
  • ...with insulin resistance may not be able to cope with the extra demand for insulin production and the blood glucose levels will be higher resulting in gestati ...lly return to normal and the gestational diabetes disappears, however this insulin resistance increases the risk of developing type 2 diabetes in later life.<
    12 KB (1,661 words) - 07:01, 21 August 2022
  • ...ty to the protein [[insulin]] (type 2), or due to inadequate production of insulin by the&nbsp;pancreas (type 1). There are two main types of diabetes: type 1 ...a cells)&nbsp;are produced. Glucagon raises the blood glucose level, while insulin lowers it.&nbsp;
    17 KB (2,468 words) - 17:37, 31 October 2023
  • #[[Insulin]] sensitivity increases after long-term exercise. ...glucose levels.  Glucagon levels subsequently increase (with exercise) and insulin levels at the same time are suppressed. This ensures that blood glucose lev
    8 KB (1,156 words) - 09:00, 27 August 2022
  • ...[[Hyperglycemia|hyperglcaemia]] following a disorder of insulin secretion, insulin action or both.<ref>Alberti KG, Zimmet PZ. [https://doi.org/10.1002/(SICI)1 ...2 Diabetes]] (T2D). Previously referred to as adult onset diabetes or non insulin dependent diabetes, risk factors for T2D may include:
    15 KB (2,113 words) - 18:06, 24 January 2023
  • ...cribed metformin, either alone or in combination with other pills, or with insulin injections.<ref name=":0">Corcoran C, Jacobs TF. Metformin, in StatPearls. ...[Liver Disease|liver,]] decreasing intestinal absorption, and increasing [[insulin]] sensitivity.Metformin decreases both basal and postprandial blood glucose
    6 KB (726 words) - 18:19, 24 January 2023
  • ...AAGBfm0DhTHX0gLuxRivB0GjNm3hXRVaXw Acromegaly: a review of current medical therapy and new drugs on the horizon.] Neurosurg Focus 2010;29(4):E15.</ref><ref na ...vels of growth hormone and [[Insulin Like Growth Factor-1 (IGF-1)|IGF-1]] (insulin-like growth factor 1)
    10 KB (1,406 words) - 09:25, 19 August 2022
  • ...ncreased, but insulin-like growth factor levels are reduced. This leads to insulin intolerance == Physical Therapy Management ==
    11 KB (1,469 words) - 13:19, 6 January 2022
  • ...pedia.com/Diabetes Diabetes mellitus] - 15% insulin-dependent and 13% non-insulin-dependent have diabetic thoracic polyradiculopathy.<ref name="p2">Non-Surgi * physical therapy
    10 KB (1,299 words) - 12:41, 25 April 2020
  • ...rter type 4, and improving [[Insulin in the Treatment of Diabetes Mellitus|insulin]] sensitivity. [[Category:Exercise Therapy]]
    8 KB (1,071 words) - 11:15, 17 February 2023
  • ...provide pharmacological resources for management of Psychoses in Physical Therapy practice. == Introduction to Types of Drug Therapy Used in the Treatment of Psychosis ==
    6 KB (852 words) - 12:26, 20 July 2019
  • * Exogenous testosterone replacement therapy ...triglycerides. AD is a typical feature of obesity, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus.<ref>Musunuru K. Atherogenic [http
    7 KB (979 words) - 01:23, 23 December 2023
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)